Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 463
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Drug Discovery 104
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 90
Clinical Trials 90
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 60
Diabetes Drugs 53
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,373 Results (Page 61 of 119)
- Relevance
  Sort by

Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

 Report
November 2025
183 Pages
Global

From

€4090EUR$4,500USD£3,527GBP

Antipsychotic Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Therapeutic Class; By Application; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2863EUR$3,150USD£2,469GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
June 2026
262 Pages
Global

From

€6358EUR$6,995USD£5,483GBP

Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028

 Report
July 2023
373 Pages
Global

From

€3817EUR$4,200USD£3,292GBP

AI in Oncology Market, till 2040: Distribution by Type of Cancer, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts

 Report
January 2026
165 Pages
Global

From

€4362EUR$4,799USD£3,762GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
925 Pages
Global

From

€2272EUR$2,500USD£1,960GBP

Translational Regenerative Medicine Market Report 2024-2034

 Report
February 2024
270 Pages
Global

From

€5221EUR$5,945USD£4,350GBP

Targeted Protein Degradation Market - Global Strategic Business Report

 Report
June 2026
384 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Biologics - Global Strategic Business Report

 Report
June 2026
495 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Peptide Therapeutics - Global Strategic Business Report

 Report
June 2026
486 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Biological Drugs - Global Strategic Business Report

 Report
June 2026
262 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Microbial API - Global Strategic Business Report

 Report
June 2026
466 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Antibody Therapeutics Market - Global Strategic Business Report

 Report
June 2026
577 Pages
Global

From

€5317EUR$5,850USD£4,586GBP

Deep Learning Market in Drug Discovery and Diagnostics - Industry Trends and Global Forecasts to 2035: By Therapeutic Areas and Key Geographical Regions

 Report
September 2025
420 Pages
Global

From

€4362EUR$4,799USD£3,762GBP

Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3772EUR$4,150USD£3,253GBP

Osteoporosis - Pipeline Review, H2 2020

 Drug Pipelines
October 2020
375 Pages
Global

From

€1818EUR$2,000USD£1,568GBP

Needle-Free Devices: Technologies and Global Markets

 Report
June 2025
156 Pages
Global

From

€4226EUR$4,650USD£3,645GBP

Active Pharmaceutical Ingredient (API) Market in the US 2025-2029

 Report
May 2025
177 Pages
United States

From

€2272EUR$2,500USD£1,960GBP

Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
110 Pages
Global

From

€5408EUR$5,950USD£4,664GBP

Mouth Ulcers Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

 Report
June 2023
115 Pages
Global

From

€4090EUR$4,500USD£3,527GBP

2,373 Results (Page 61 of 119)
- 1
- 59
- 60
- 61
- 62
- 63

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.